Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2025-02-18 00:00:00 ET · period of report 2025-02-12 · accession 0001846478-25-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-18 | 2025-02-14+ | ANIP | Gutwerg Ori | SVP, GENERICS | F - Tax | $58.92 | -2,593 | 101.9K | -2% | -$152.8K |
| M | 2025-02-18 | 2025-02-12 | ANIP | Gutwerg Ori | SVP, GENERICS | A - Grant | $0.00 | +26.1K | 103.3K | +34% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-15 | F | D | 1,167 | $58.92 | 100,746 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-14 | F | D | 1,426 | $58.92 | 101,913 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-12 | A | A | 15,668 | $0.00 | 92,895 | D | — | — | |
| 4 | Common | Common Stock | 2025-02-12 | A | A | 10,444 | $0.00 | 103,339 | D | — | — |